Skip to main content

Rafael Holdings, Inc.

corporate_fare Company Profile

Rafael Holdings, Inc.

RFL·NYSE·Life Sciences·CIK 0001713863

Rafael Holdings, Inc. is a biotechnology company that develops pharmaceuticals and holds interests in clinical and early-stage companies developing pharmaceuticals and medical devices. Its lead candidate is Trappsol® Cyclo™ (remibetadex), an investigational therapy for the potential treatment of Niemann-Pick Disease Type C (NPC), a rare, fatal and progressive genetic disorder. The company completed the pivotal Phase 3 clinical trial of Trappsol® Cyclo™ and on October 28, 2026 submitted a New Drug Application to the U.S. Food and Drug Administration. Its primary focus is obtaining FDA approval of Trappsol® Cyclo™ and, if approved, bringing the product to market. The company also holds: (i) a majority equity interest in LipoMedix Pharmaceuticals Ltd., a clinical stage pharmaceutical company; (ii) Barer Institute Inc., a wholly-owned subsidiary holding equity interests in early stage cancer assets; (iii) a majority equity, and debt, interest in Cornerstone Pharmaceuticals, Inc., formerly known as Rafael Pharmaceuticals Inc., a cancer metabolism-based therapeutics company; (iv) a majority equity interest in Rafael Medical Devices, LLC, an orthopedic-focused medical device company developing instruments to advance minimally invasive surgeries; and (v) a majority equity interest in Day Three Labs, Inc., which empowers third-party manufacturers to bring to market better, cleaner, more precise and predictable versions of their product by utilizing Day Three's technology and which holds equity and debt interests in two industry related companies. Rafael also evaluates opportunities to expand its investment portfolio through strategic investments, including in therapeutics addressing high unmet medical needs, and continuously evaluates its other holdings to focus resources on core assets, specifically Trappsol® Cyclo™ clinical development and commercialization. Historically, it owned real estate assets; as of July 31, 2026, it holds a portion of a commercial building in Jerusalem, Israel as its sole remaining real estate asset.

Rafael Holdings, Inc. (NYSE:RFL) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 14 items for RFL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for RFL spans DEF 14A, 10-K, 8-K, 10-Q.

Recent high-impact activity:

  • Rafael Proxy Seeks 2.42M More Plan Shares to Enable 1.93M Options Tied to FDA Approval
  • Rafael Holdings 10-K: Going-Concern Warning With $22.1M Cash After $29.6M FY2026 Loss
  • Rafael Holdings Posts $29.6M FY2026 Loss, $22.1M Cash, Confirms NDA Filing
  • Rafael Files FDA NDA for NPC Drug Despite Phase 3 Miss
  • Trappsol Cyclo Misses Phase 3 Primary Endpoint but Shows Survival Benefit

Financial Snapshot

Fiscal year ended July 31, 2026
Revenue
874K
Net Income
-29.64M
Diluted EPS
-0.58
Op. Cash Flow
-29.99M
Free Cash Flow
-29.99M
Operating Income
-33.41M
Cash & Equivalents
22.07M
Debt / Equity
0.00×
Net Margin
-33.91×
Shares Outstanding
51.39M sh
Source: 10-K · filed 2026-10-29 · accession 0001213900-26-113659

Short Interest & Short Volume

5.19 days to cover

FINRA reported short interest of 292,865 shares in RFL as of the October 30, 2026 settlement, a 15.9% decrease from the prior period — about 5.2 days to cover at its recent average daily volume. On November 20, 2026, 66.1% of RFL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)292,865 shares as of October 30, 2026
Change vs prior period▼ 15.9%
Days to cover5.19 at avg daily volume of 56,472
Daily short volume (FINRA facilities)66.1% of 102,373 shares on November 20, 2026
5-day average short volume49.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with R →
$0.9197
52-week range · as of 2026-11-16 $0.9197 – $3.96
Market cap
$48M
Volume
156.5K (2.3× avg)
3-mo avg 67.7K
Live data · 2026-11-21 09:05 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed RFL - Latest Insights

RFL
Nov 16, 2026, 8:15 AM EST
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.08
Real-time Price: $0.9197 info
Change: -$0.1603 (-15%) info
Market Cap: $48.005M info
RFL
Oct 29, 2026, 11:35 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $1.20
Real-time Price: $0.9197 info
Change: -$0.2753 (-23%) info
Market Cap: $48.005M info
RFL
Oct 29, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.9197 info
Change: -$0.2203 (-19%) info
Market Cap: $48.005M info
RFL
Oct 29, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.14
Real-time Price: $0.9197 info
Change: -$0.2203 (-19%) info
Market Cap: $48.005M info
RFL
Sep 30, 2026, 7:23 AM EDT
Filing Type: 8-K
Importance Score:
9
Updated Sep 30, 2:42 PM ET — Rafael shares fell 37.89% to $1.26 on volume of 1.90 million shares, more than 12 times the 100-day average.
Price at Filing: $1.32
Real-time Price: $0.9197 info
Change: -$0.4003 (-30%) info
Market Cap: $48.005M info
RFL
Sep 30, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.24
Real-time Price: $0.9197 info
Change: -$0.3203 (-26%) info
Market Cap: $48.005M info
RFL
Jul 08, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.57
Real-time Price: $0.9197 info
Change: -$1.65 (-64%) info
Market Cap: $48.005M info
RFL
Jun 11, 2026, 8:17 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.84
Real-time Price: $0.9197 info
Change: -$0.9203 (-50%) info
Market Cap: $48.005M info
RFL
Jun 11, 2026, 8:03 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $0.9197 info
Change: -$0.7503 (-45%) info
Market Cap: $48.005M info
RFL
Jun 10, 2026, 7:49 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.93
Real-time Price: $0.9197 info
Change: -$1.01 (-52%) info
Market Cap: $48.005M info
RFL
Apr 22, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.26
Real-time Price: $0.9197 info
Change: -$0.3403 (-27%) info
Market Cap: $48.005M info
RFL
Mar 16, 2026, 4:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.9197 info
Change: -$0.3903 (-30%) info
Market Cap: $48.005M info
RFL
Mar 16, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $0.9197 info
Change: -$0.3903 (-30%) info
Market Cap: $48.005M info
RFL
Jan 12, 2026, 4:29 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.26
Real-time Price: $0.9197 info
Change: -$0.3397 (-27%) info
Market Cap: $48.005M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets